SCHEMBL519522

SCHEMBL519522

O=CC1CCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2262060 1.00
SCHEMBL13471186 1.00
Water SCHEMBL27991468 0.94
SCHEMBL2267946 0.85
SCHEMBL475385 0.85
SCHEMBL80843 0.85
Acetic Acid SCHEMBL16660460 0.84 SLC1A2 (0.37)
SCHEMBL4955062 0.83
SCHEMBL3679748 0.83
Hydrochloric Acid SCHEMBL28298516 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 539 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116457355-A 2-amino-3-carbonyl imidazopyridines and pyrazolopyridines compounds 第一生物治疗股份有限公司 2023-07-18 CN claimed
CN-116162110-A Polymerizable phosphorus-containing flame retardant, and preparation method and application thereof 烟台锦合晟新材料科技有限公司 2023-05-26 CN claimed
CN-105492439-B Substituted dicyclic compound as bromine structural domain inhibitor 齐尼思表观遗传学有限公司 2019-11-22 CN claimed
CN-109311872-A 1H- pyrazolo [4,3-b] pyridine as PDE1 inhibitor H.隆德贝克有限公司 2019-02-05 CN claimed
CN-107709316-A The benzodioxan derivative of 2 (base of 1 heteroaryl piperazine 4) methyl 1,4 as α 2C antagonists 奥赖恩公司 2018-02-16 CN claimed
CN-106417360-A Synergistic peroxide based biocidal compositions 隆萨公司 2017-02-22 CN claimed
CN-105492439-A Novel substituted bicyclic compounds as bromodomain inhibitors ZENITH EPIGENETICS CORP 2016-04-13 CN claimed
CN-105407888-A Novel bicyclic bromodomain inhibitors ZENITH EPIGENETICS CORP 2016-03-16 CN claimed
CN-105189512-A Pyrrolopyrimindine CDK9 kinase inhibitors ABBVIE INC 2015-12-23 CN claimed
CN-103059046-B Preparation method of faropenem SUZHOU ERYE PHARMACEUTICAL CO 2015-01-07 CN claimed
WO-1996040752-A1 NOVEL DOLASTATIN DERIVATIVES, THEIR PREPARATION AND USE BASF AKTIENGESELLSCHAFT (DE) 1996-12-19 WO claimed
WO-1996040751-A1 NOVEL DOLASTATIN DERIVATIVES, THEIR PREPARATION AND USE BASF AKTIENGESELLSCHAFT (DE) 1996-12-19 WO claimed
EP-0578521-A1 New peptide derivatives with bradykinin-antagonistic activity, process to prepare them and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1994-01-12 EP claimed
CN-1067429-A The 4-substituted alkyl carbapenem antibiotics BRISTOL MYERS SQUIBB CO (US) 1992-12-30 CN claimed
EP-0280610-B1 DIPEPTIDES, PREPARATION PROCESS AND USE IN DOSING PROTEASES SERBIO (FR) 1992-10-21 EP claimed
CN-1058392-A Mycocide ICI PLC (GB) 1992-02-05 CN claimed
US-4448715-A Tagged pyroglu-L-Phe-L-Arg derivatives, substrates and assays for kallikrein UNIVERSITY OF MIAMI (US) 1984-05-15 US claimed
EP-0078703-A2 New tagged pyroglu-l-phe-l-arg derivatives, substrates and assays for kallikrein UNIVERSITY OF MIAMI (US) 1983-05-11 EP claimed
US-4118482-A Process for treating neoplastic disease with azetomicins THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1978-10-03 US claimed
US-4053460-A ACTINOMYCIN ANTIBIOTIC ANALOGUES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1977-10-11 US claimed